PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1270319
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1270319
The Isothermal Nucleic Acid Amplification Technology Market size was valued at USD 4,008.1 million in 2022, expanding at a CAGR of 10.8% from 2023 to 2030.
The isothermal nucleic acid amplification technology market refers to the global market for nucleic acid amplification techniques that can occur at a constant temperature, without the need for thermal cycling. This technology is used for the amplification of nucleic acid sequences for various applications in the fields of research, diagnostics, and therapeutics. Some of the common isothermal nucleic acid amplification technologies include loop-mediated isothermal amplification (LAMP), nucleic acid sequence-based amplification (NASBA), recombinase polymerase amplification (RPA), and helicase-dependent amplification (HDA). The factors driving the market growth include technological advancements in nucleic acid amplification, increasing research and development activities, and rising investments from government and private organizations.
Isothermal Nucleic Acid Amplification Technology Market- Market Dynamics
The market for isothermal nucleic acid amplification technology is expected to grow significantly in the coming years due to the increasing demand for Rapid and Accurate Diagnostic Tests. Isothermal nucleic acid amplification technology is increasingly being used for rapid and accurate diagnostic tests, especially in the fields of infectious diseases and cancer. The ability to perform nucleic acid amplification at a constant temperature without the need for thermal cycling makes it ideal for point-of-care testing. According to the World Health Organization (WHO), cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths in 2018. The growing prevalence of infectious diseases and cancer is expected to increase the demand for isothermal nucleic acid amplification technology for the diagnosis and monitoring of these diseases.
Furthermore, Isothermal nucleic acid amplification technology has played a crucial role in the detection of COVID-19, the disease caused by the SARS-CoV-2 virus. It has been used to develop rapid diagnostic tests for COVID-19. These tests can provide results in as little as 15-30 minutes, allowing for quick and efficient testing and diagnosis of COVID-19. Overall, isothermal nucleic acid amplification technology has been instrumental in the fight against COVID-19, allowing for rapid and accurate diagnosis, point-of-care testing, and molecular surveillance of the virus.
The Global Isothermal Nucleic Acid Amplification Technology Market is segmented on the basis of Product Type, Technology, Application, and Region.
The Global Isothermal Nucleic Acid Amplification Technology market is divided into three categories based on product type: Instruments and Reagent. The reagents segment dominated the market in 2021 due to the extensive usage in hospitals and primary healthcare settings, as well as the increasing obtainability of polymerases with high strand displacement capabilities.
The market is divided into five categories based on Technology: Loop-mediated isothermal amplification, Strand displacement Amplification, Nucleic acid sequence-based Amplification, Helicase-dependent Amplification, and others. Loop-mediated isothermal amplification (LAMP) accounted for the largest market share in 2021. LAMP is a widely used INAAT technology that uses four to six primers and a DNA polymerase with strand displacement activity to amplify DNA at a constant temperature. LAMP is known for its high specificity and sensitivity and can be used for the detection of a wide range of pathogens. INAAT technologies are becoming increasingly popular due to their simplicity, speed, and accuracy. These technologies have numerous applications, including the diagnosis of infectious diseases, genetic testing, and environmental monitoring.
The market is divided into three categories based on application: Hospitals, Central & Reference Labs, and Others. Hospitals dominate the market and are likely to maintain their dominance during the forecast period. Hospitals are a significant end-user of INAAT technology, primarily for the rapid and accurate diagnosis of infectious diseases. INAAT-based diagnostic tests have several advantages over traditional diagnostic methods, including reduced turnaround time, increased sensitivity and specificity, and ease of use. With the increasing prevalence of infectious diseases and the need for prompt and accurate diagnosis, the demand for INAAT-based diagnostic tests is expected to grow significantly in the coming years.
Isothermal Nucleic Acid Amplification Technology Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
North America is expected to hold the largest share of the isothermal Nucleic Acid Amplification Technology market, primarily due to the high adoption rate of advanced molecular diagnostic technologies, increasing healthcare expenditure, and the presence of major players in the region. According to the Centers for Medicare and Medicaid Services (CMS), healthcare spending in the United States reached USD 3.8 trillion in 2019, accounting for 17.7% of the country's gross domestic product (GDP). The United States is the largest market for INAAT in North America due to the presence of a large number of research institutes, academic centers, and biotechnology and pharmaceutical companies.
Europe is expected to hold a significant share of the INAAT market due to the increasing prevalence of infectious diseases and the growing demand for rapid and accurate diagnostic tests. Also, the rising geriatric population and the growing focus on healthcare infrastructure development are also expected to drive the growth of the INAAT market in the Asia Pacific region. Overall, the INAAT market is expected to witness significant growth globally, with North America and Europe being the largest markets, and Asia-Pacific expected to grow at the highest CAGR.
The INAAT market is highly competitive, with many companies offering various products and services. The manufacturers are continuously investing in R&D activities to develop innovative products, which are more efficient and user-friendly. They are also engaged in strategic partnerships, collaborations, mergers, and acquisitions to strengthen their market position and expand their product portfolio. For example, Thermo Fisher Scientific, for instance, has been investing heavily in expanding its product portfolio in the isothermal nucleic acid amplification technology market. The company has acquired Mesa Biotech Inc. and Alfa Aesar to enhance its capabilities in the development of isothermal amplification technologies.
This proposed research study on Isothermal Nucleic Acid Amplification Technology market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Isothermal Nucleic Acid Amplification Technology market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Isothermal Nucleic Acid Amplification Technology market
Impact of COVID-19 on Isothermal Nucleic Acid Amplification Technology market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Isothermal Nucleic Acid Amplification Technology market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Isothermal Nucleic Acid Amplification Technology market, we have also included competitive landscape and key innovator analysis for the Isothermal Nucleic Acid Amplification Technology market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Isothermal Nucleic Acid Amplification Technology market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Isothermal Nucleic Acid Amplification Technology market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET KEY PLAYERS
Eiken Chemical Co. Ltd
Meridian Bioscience, Inc.
Ustar Biotechnologies Ltd.
Thermo Fisher Scientific, Inc.
BD (Becton, Dickinson & Company)
GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT TYPE.
GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY
Loop-mediated isothermal amplification
Strand displacement Amplification
Nucleic acid sequence-based Amplification
GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER
Central & Reference Labs
GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA